Wouter Meuleman work email
- Valid
- Valid
- Valid
Wouter Meuleman personal email
Wouter Meuleman phone numbers
Scientist | Venture Capitalist | Skateboarder
-
PartnerIllumina Ventures Jul 2020 - PresentIllumina Ventures pursues investments in early stage companies that are pioneering new applications of nucleic acid sequencing, developing products that will expand the genomics ecosystem, and utilizing genomics to improve human health. -
PrincipalIllumina Ventures Feb 2016 - Jun 2020
-
Board ObserverPrecede Biosciences Nov 2022 - PresentBoston, Ma, UsPrecede Biosciences is breaking down the barriers to precision medicine by redefining what can be learned from a simple blood draw. By understanding the fundamental biology behind disease at any given moment, researchers and clinicians can better target medicines to the right patients in both drug development and clinical practice. Precede seeks to improve success rates for developers of new medicines and to be a part of building a future where every patient can receive a rapid, minimally invasive diagnosis and therapy that is precise to the biology of their disease. -
Board MemberRedshiftbio Oct 2021 - PresentBoxborough, Ma, UsRedShiftBio has developed a proprietary life sciences platform combining its Microfluidic Modulation Spectroscopy (MMS) and expertise in high powered quantum cascade lasers that provides ultra-sensitive and ultra-precise measurements of molecular structure. -
Board MemberLightcast Discovery Mar 2021 - PresentCambridge, England, GbLightcast Discovery is developing a flexible, accessible platform to accelerate single-cell, functional analysis at scale. Consolidating multiple, complex assays into intuitive streamlined workflows, the company is addressing key limitations in existing methods to provide the freedom to innovate and discover across a broad range of disciplines, from basic and translational research to drug discovery. -
Board MemberFluent Biosciences Inc. Mar 2019 - PresentWatertown, Massachusetts, UsFluent BioSciences, develops high sensitivity molecular analytical products that enables usage of extremely low molecular and cellular sample inputs. -
Board ObserverRibometrix Nov 2018 - PresentDurham, North Carolina, UsRibometrix is a platform therapeutics company discovering small-molecule drugs that target functional RNA structures to create new avenues to treat human disease. -
Board ObserverDelfi Diagnostics Aug 2019 - PresentBaltimore, Maryland, Us -
Board MemberBiota Technology Oct 2015 - PresentHouston, Tx, UsBiota applies DNA sequencing and data science to explore the earth's subsurface. It offers DNA data services for production profiling, sweet spot identification, and reservoir connectivity. -
Board ObserverDna Script Aug 2017 - PresentLe Kremlin-Bicêtre, Île-De-France, FrDNA Script is focused on the manufacturing of synthetic DNA using a proprietary template-free enzymatic technology. This technology has the potential to greatly accelerate the development of new therapeutics, sustainable chemical production, improved crops as well as new applications such as data storage. -
Director, Corporate And Business DevelopmentIllumina Jan 2015 - Mar 2019San Diego, Ca, UsIllumina, Inc. is a Life Sciences tools company developing, manufacturing and marketing integrated systems for the analysis of genetic variation and biological function. -
Principal ScientistIllumina Dec 2011 - Dec 2014San Diego, Ca, Us
-
Senior Staff ScientistIllumina Sep 2010 - Dec 2011San Diego, Ca, Us
-
Staff ScientistIllumina Sep 2009 - Sep 2010San Diego, Ca, Us
-
Board ObserverDesktop Genetics Dec 2015 - Jul 2018Cambridge, Massachusetts, UsDesktop Genetics aims to help researchers discover and treat the root genetic causes of human disease. The company offers sgRNA design tools, custom CRISPR library design, and analysis services to investigators globally. Desktop Genetics was acquired by Celixir in May, 2018. -
Project LeaderOxford Gene Technology Jan 2005 - Aug 2008Kidlington, Oxfordshire, GbFounded by Professor Ed Southern, Oxford Gene Technology (OGT) provides innovative genetics research solutions to advance molecular medicine. -
Senior ScientistOxamer Jun 2003 - Dec 2004Oxamer was founded in the autumn of 2002 by Professor Edwin M. Southern, Ryan D. Egeland, and John Jarvis to commercialise an electrochemical method for DNA microarray fabrication.
-
Post-Doctoral ResearcherNewcastle University May 2001 - May 2003Newcastle Upon Tyne, Tyne And Wear, GbResearch on methanol reformate fuel cells; synthesis and characterization of methanol resistant electrocatalysts; recovery of precious metals from catalyst waste.
Wouter Meuleman Skills
Wouter Meuleman Education Details
-
University Of CambridgeMaster Of Business Administration (Mba) -
Newcastle UniversityChemical Engineering
-
Ghent UniversityChemistry
-
Sint-Lodewijkscollege BruggeMathematics & Sciences
Frequently Asked Questions about Wouter Meuleman
What company does Wouter Meuleman work for?
Wouter Meuleman works for Illumina Ventures
What is Wouter Meuleman's role at the current company?
Wouter Meuleman's current role is Life Science Investor.
What is Wouter Meuleman's email address?
Wouter Meuleman's email address is wm****@****ina.com
What is Wouter Meuleman's direct phone number?
Wouter Meuleman's direct phone number is +185825*****
What schools did Wouter Meuleman attend?
Wouter Meuleman attended University Of Cambridge, Newcastle University, Ghent University, Sint-Lodewijkscollege Brugge.
What skills is Wouter Meuleman known for?
Wouter Meuleman has skills like Start Ups, Materials Science, Life Sciences, Venture Capital, Genomics.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial